Online Resources Corporation ORCC dipped 25.62% to $4.50 in the pre-market session. Analysts at Oppenheimer downgraded ORCC from “outperform” to “perform.”
Amylin Pharmaceuticals Inc AMLN fell 3.45% to $10.65 in the pre-market session. AMLN suspended clinical activities in an ongoing Phase 2 study for the treatment of obesity.
Energy Conversion Devices Inc ENER moved down 2.53% to $2.31 in the pre-market session. Analysts at Morgan Stanley downgraded ENER from “equal weight” to “underweight.”
Star Scientific Inc CIGX dropped 1.70% to $2.89 in the pre-market trading. The US Patent and Trademark Office confirmed the validity of two of CIGX's patents.
Read more from Benzinga's Markets.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
